Health Populi

MARCH 11, 2021

Their research mines data from the Medicare Part D drug benefit program to identify several facts about consumer-facing drug costs, behavior change in consumption/use, and resulting patient mortality: An increase of one-third in a patient’s out-of-pocket price — about $10.40

Health Policy 245

Health Policy Medicare Pharmaceuticals Life Science 245

Health Populi

OCTOBER 28, 2019

Taken together, these two data points demonstrate the potent political import of prescription drug prices as the U.S. Hospital costs contribute to rising medical costs to 49% of health consumers. People in the U.S. approaches the 2020 Presidential election. The Physicians Foundation surveyed 2,001 U.S.

Pharmaceuticals 136

Pharmaceuticals Medical Billing Medicare Mental health 136

Health Populi

JULY 10, 2018

.” In the sample, two-thirds of respondents had seen a health care provider for an illness or medical condition in the past 12 months, so two-thirds of the survey sample have faced a medical encounter yielding some kind of medical bill in the past year. The second chart shows the roughly 50/50 split of U.S.

BioTech 120

BioTech Medical Billing Life Science Pharmaceuticals 120

Health Populi

MAY 19, 2019

This poll from RealClear Politics , conducted in late April/early May 2019, makes my point that the patient is the consumer and, facing deductibles and more financial exposure to footing the medical bill, the payor. Only 4% of people say American health care is “working well.”

Life Science 149

Life Science BioTech Medicare Medical Billing 149